Kiromic Biopharma, Inc.

About Kiromic Biopharma, Inc.

Kiromic BioPharma is a clinical-stage biotherapeutics company developing allogeneic Gamma Delta T-cell therapies targeting solid tumors. Its proprietary AI platform identifies tumor-specific targets, enabling the creation of off-the-shelf immunotherapies. The company focuses on innovative, cost-effective cell products with potential for broad cancer treatment, leveraging bioinformatics, bioengineering, and GMP manufacturing to address unmet needs in oncology markets.